Arjuna Capital Novo Nordisk A S Transaction History

Arjuna Capital

$349 Million
Q1 2025

A detailed history of Arjuna Capital transactions in Novo Nordisk A S stock. As of the latest transaction made, Arjuna Capital holds 35,639 shares of NVO stock, worth $2.55 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

35,639

Previous 37,517 5.01%

Holding current value

$2.55 Million

Previous $3.23 Million 23.33%

% of portfolio

0.71%

Previous 0.89%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$69.3 - $90.95 $130,145 - $170,804	-1,878 Reduced 5.01%	35,639 $2.47 Million
Q4 2024 Feb 07, 2025	SELL	$85.0 - $120.04 $828,750 - $1.17 Million	-9,750 Reduced 20.63%	37,517 $3.23 Million
Q3 2024 Nov 05, 2024	SELL	$119.07 - $145.42 $728,232 - $889,388	-6,116 Reduced 11.46%	47,267 $5.63 Million
Q2 2024 Jul 29, 2024	SELL	$122.71 - $146.91 $2,086 - $2,497	-17 Reduced 0.03%	53,383 $7.62 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $1.09 Million - $1.45 Million	10,696 Added 25.05%	53,400 $6.86 Million
Q4 2023 Feb 08, 2024	BUY	$87.78 - $105.45 $184,864 - $222,077	2,106 Added 5.19%	42,704 $4.42 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $1.81 Million - $3.98 Million	19,941 Added 96.53%	40,598 $3.69 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $12,322 - $13,639	79 Added 0.38%	20,657 $3.34 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $424,282 - $510,202	-3,206 Reduced 13.48%	20,578 $3.27 Million
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $63,068 - $83,227	-615 Reduced 2.52%	23,784 $3.22 Million
Q3 2022 Nov 01, 2022	BUY	$95.28 - $116.93 $78,701 - $96,584	826 Added 3.5%	24,399 $2.43 Million
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $51,207 - $60,417	496 Added 2.15%	23,573 $2.63 Million
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $105,575 - $127,620	-1,134 Reduced 4.68%	23,077 $2.56 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $280,257 - $342,224	2,923 Added 13.73%	24,211 $2.71 Million
Q3 2021 Nov 08, 2021	BUY	$84.42 - $106.62 $208,010 - $262,711	2,464 Added 13.09%	21,288 $2.04 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $202,574 - $253,771	2,994 Added 18.91%	18,824 $1.58 Million
Q1 2021 May 11, 2021	BUY	$67.06 - $75.82 $846,028 - $956,545	12,616 Added 392.53%	15,830 $1.07 Million
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $3,386 - $3,911	53 Added 1.68%	3,214 $224,000
Q3 2020 Nov 05, 2020	SELL	$63.69 - $70.22 $9,362 - $10,322	-147 Reduced 4.44%	3,161 $219,000
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $193,650 - $224,745	3,308 New	3,308 $217,000

Others Institutions Holding NVO

# of Institutions

1,769

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $161B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

News

Stay updated on Arjuna Capital with notifications on news.

Account